You can find the annual or quarterly income statement of Icecure Medical Ltd here for insights into the performance and operational efficiency of Icecure Medical Ltd.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q2

FY2021Q1

FY2020H1

FY2019H2

FY2019H1

FY2018Q4

FY2018Q3

FY2017Q4

FY2017Q3

FY2017H2

FY2017H1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

Total revenue

25.66%911.00K

46.17%1.28M

28.40%850.00K

-48.07%525.00K

-2.42%725.00K

-30.28%875.00K

102.45%662.00K

7.90%1.01M

4.65%743.00K

33.65%1.25M

-48.42%327.00K

22.48%937.00K

-4.95%710.00K

--939.00K

--634.00K

20.09%765.00K

-47.98%747.00K

--637.00K

--1.44M

229.20%1.83M

--1.06M

--557.12K

479.78%335.49K

67.62%285.60K

-36.37%57.87K

-14.96%170.39K

--229.01K

--433.49K

--90.94K

--200.36K

--164.32K

--171.72K

Revenue

25.66%911.00K

46.17%1.28M

28.40%850.00K

-48.07%525.00K

-2.42%725.00K

-30.28%875.00K

102.45%662.00K

7.90%1.01M

4.65%743.00K

33.65%1.25M

-48.42%327.00K

22.48%937.00K

-4.95%710.00K

--939.00K

--634.00K

20.09%765.00K

-47.98%747.00K

--637.00K

--1.44M

229.20%1.83M

--1.06M

--557.12K

479.78%335.49K

67.62%285.60K

-36.37%57.87K

-14.96%170.39K

--229.01K

--433.49K

--90.94K

--200.36K

--164.32K

--171.72K

Cost of revenue

21.50%616.00K

48.25%679.00K

34.19%573.00K

-18.09%394.00K

6.96%507.00K

-33.24%458.00K

22.00%427.00K

-4.37%481.00K

21.54%474.00K

43.51%686.00K

-25.21%350.00K

32.02%503.00K

24.60%390.00K

--478.00K

--468.00K

-0.52%381.00K

-37.02%313.00K

--383.00K

--497.00K

54.02%652.93K

--630.20K

--423.92K

167.64%212.86K

-4.65%151.48K

-32.22%79.53K

43.50%158.86K

--238.91K

--257.85K

--117.33K

--110.70K

--93.45K

--84.07K

Operating expenses

17.71%5.16M

1.76%5.50M

-5.43%4.69M

-7.76%3.91M

-0.25%4.38M

15.63%5.40M

11.35%4.96M

-15.52%4.24M

-5.87%4.39M

-4.13%4.67M

-6.02%4.45M

-0.55%5.02M

-9.76%4.67M

--4.87M

--4.74M

58.18%5.05M

96.73%5.17M

--3.19M

--2.63M

17.33%3.38M

--3.21M

--2.88M

79.24%1.26M

27.20%1.09M

-13.35%701.22K

16.99%859.80K

--1.56M

--1.68M

--809.30K

--734.93K

--954.44K

--1.23M

R&D expenses

32.87%2.21M

35.46%2.30M

-5.52%1.76M

7.95%1.71M

-14.71%1.66M

-9.98%1.69M

-15.23%1.86M

-23.76%1.58M

-7.58%1.95M

-15.82%1.88M

-1.65%2.20M

-7.80%2.08M

-11.82%2.11M

--2.24M

42.18%2.25M

109.27%2.39M

--1.59M

--1.14M

3.05%1.46M

--1.35M

--1.42M

87.54%484.87K

38.43%549.17K

-30.42%258.54K

16.78%396.72K

--656.16K

--789.13K

--371.59K

--339.72K

--393.48K

--560.79K

Depreciation, depletion, and amortization

-22.47%69.00K

-13.41%71.00K

-12.05%73.00K

-24.39%62.00K

4.71%89.00K

-1.20%82.00K

1.22%83.00K

3.80%82.00K

7.59%85.00K

12.16%83.00K

17.14%82.00K

51.92%79.00K

--74.00K

--70.00K

92.59%52.00K

126.09%52.00K

--27.00K

--23.00K

70.75%101.92K

--91.82K

--59.69K

----

--11.89K

--20.21K

--12.80K

--12.88K

--14.17K

--14.35K

Operating profit

-16.13%-4.25M

6.83%-4.22M

10.65%-3.84M

-4.86%-3.38M

-0.19%-3.66M

-32.50%-4.53M

-4.12%-4.29M

20.90%-3.23M

7.76%-3.65M

13.15%-3.42M

-0.54%-4.12M

4.67%-4.08M

10.58%-3.96M

---3.93M

---4.10M

-67.69%-4.28M

-270.91%-4.42M

---2.55M

---1.19M

33.40%-1.55M

---2.15M

---2.33M

-43.21%-921.38K

-17.21%-808.06K

10.44%-643.36K

-28.97%-689.41K

---1.33M

---1.24M

---718.36K

---534.57K

---790.12K

---1.06M

Net non-operating interest income (expenses)

Non-operating interest income

----

-85.71%21.00K

68.29%69.00K

-89.05%46.00K

17.07%144.00K

-23.44%147.00K

-78.31%41.00K

--420.00K

186.05%123.00K

--192.00K

--189.00K

----

--43.00K

----

--77.00K

----

--16.27K

--35.93K

----

-72.73%285.05

----

--283.07

--1.64K

--1.05K

--525.89

--787.49

--1.54K

Non-operating interest expense

--27.00K

--30.00K

--23.00K

----

--20.00K

----

--240.00K

-87.64%22.00K

----

--178.00K

74.20%188.71K

--87.26K

--108.33K

44.95%97.51K

-18.24%55.63K

31.34%67.27K

58.75%68.04K

--135.31K

--71.57K

--51.22K

--42.86K

--39.64K

--37.42K

Income before tax

-19.12%-4.27M

5.20%-4.25M

6.99%-3.86M

-9.19%-3.36M

0.58%-3.59M

-49.55%-4.48M

-3.72%-4.15M

20.78%-3.08M

4.22%-3.61M

24.22%-3.00M

1.43%-4.00M

13.98%-3.89M

15.27%-3.77M

---3.95M

---4.06M

-82.59%-4.52M

-224.36%-4.45M

---2.48M

---1.37M

29.28%-1.72M

---2.20M

---2.44M

-43.44%-1.02M

-14.03%-863.70K

7.57%-710.34K

-31.30%-757.46K

---1.47M

---1.31M

---768.53K

---576.90K

---828.97K

---1.10M

Income after tax

-19.12%-4.27M

5.20%-4.25M

6.99%-3.86M

-9.19%-3.36M

0.58%-3.59M

-49.55%-4.48M

-3.72%-4.15M

20.78%-3.08M

4.22%-3.61M

24.22%-3.00M

1.43%-4.00M

13.98%-3.89M

15.27%-3.77M

---3.95M

---4.06M

-82.59%-4.52M

-224.36%-4.45M

---2.48M

---1.37M

29.28%-1.72M

---2.20M

---2.44M

-43.44%-1.02M

-14.03%-863.70K

7.57%-710.34K

-31.30%-757.46K

---1.47M

---1.31M

---768.53K

---576.90K

---828.97K

---1.10M

Net income from continuous operations

-19.12%-4.27M

5.20%-4.25M

6.99%-3.86M

-9.19%-3.36M

0.58%-3.59M

-49.55%-4.48M

-3.72%-4.15M

20.78%-3.08M

4.22%-3.61M

24.22%-3.00M

1.43%-4.00M

13.98%-3.89M

15.27%-3.77M

---3.95M

---4.06M

-82.59%-4.52M

-224.36%-4.45M

---2.48M

---1.37M

29.28%-1.72M

---2.20M

---2.44M

-43.44%-1.02M

-14.03%-863.70K

7.57%-710.34K

-31.30%-757.46K

---1.47M

---1.31M

---768.53K

---576.90K

---828.97K

---1.10M

Net income attributable to controlling interests

-19.12%-4.27M

5.20%-4.25M

6.99%-3.86M

-9.19%-3.36M

0.58%-3.59M

-49.55%-4.48M

-3.72%-4.15M

20.78%-3.08M

4.22%-3.61M

24.22%-3.00M

1.43%-4.00M

13.98%-3.89M

15.27%-3.77M

---3.95M

---4.06M

-82.59%-4.52M

-224.36%-4.45M

---2.48M

---1.37M

29.28%-1.72M

---2.20M

---2.44M

-43.44%-1.02M

-14.03%-863.70K

7.57%-710.34K

-31.30%-757.46K

---1.47M

---1.31M

---768.53K

---576.90K

---828.97K

---1.10M

Net income attributable to common shareholders

-19.12%-4.27M

5.20%-4.25M

6.99%-3.86M

-9.19%-3.36M

0.58%-3.59M

-49.55%-4.48M

-3.72%-4.15M

20.78%-3.08M

4.22%-3.61M

24.22%-3.00M

1.43%-4.00M

13.98%-3.89M

15.27%-3.77M

---3.95M

---4.06M

-82.59%-4.52M

-224.36%-4.45M

---2.48M

---1.37M

29.28%-1.72M

---2.20M

---2.44M

-43.44%-1.02M

-14.03%-863.70K

7.57%-710.34K

-31.30%-757.46K

---1.47M

---1.31M

---768.53K

---576.90K

---828.97K

---1.10M

Basic earnings per share

6.68%-0.06

26.89%-0.06

26.33%-0.06

8.87%-0.06

19.39%-0.06

-21.96%-0.08

8.62%-0.08

26.18%-0.06

6.50%-0.08

37.61%-0.07

20.44%-0.09

30.59%-0.09

31.63%-0.08

---0.11

-42.12%-0.12

-82.73%-0.12

---0.09

---0.07

38.35%-0.11

---0.16

---0.19

-112.18%-0.12

-13.95%-0.07

7.67%-0.06

-31.34%-0.06

---0.12

---0.10

---0.06

---0.05

---0.07

---0.09

Diluted earnings per share

6.68%-0.06

26.89%-0.06

26.33%-0.06

8.87%-0.06

19.39%-0.06

-21.96%-0.08

8.62%-0.08

26.18%-0.06

6.50%-0.08

37.61%-0.07

20.44%-0.09

30.59%-0.09

31.63%-0.08

---0.11

-42.12%-0.12

-82.73%-0.12

---0.09

---0.07

38.35%-0.11

---0.16

---0.19

-112.18%-0.12

-13.95%-0.07

7.67%-0.06

-31.34%-0.06

---0.12

---0.10

---0.06

---0.05

---0.07

---0.09

Dividend per share

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Icecure Medical Ltd's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing ICCM stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Icecure Medical Ltd's revenue at year end?



Icecure Medical Ltd reported 3.38M in revenue for fiscal year 2025, up from 3.29M in the previous year.

How much revenue did Icecure Medical Ltd report in the most recent quarter?



Icecure Medical Ltd reported 911.00K in revenue for the most recent quarter, an increase of 25.66% year over year.

What was Icecure Medical Ltd's net income for the year?



Icecure Medical Ltd posted -15.06M in net income for fiscal year 2025.

How much net income did Icecure Medical Ltd post in the last quarter?



Icecure Medical Ltd reported -4.27M in net income for the latest quarter。

What was Icecure Medical Ltd's annual operating profit?



Icecure Medical Ltd's operating income was -15.09M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.